Skip to main content
Beam Therapeutics Inc. logo

Beam Therapeutics Inc. — Investor Relations & Filings

Ticker · BEAM ISIN · US07373V1052 US Manufacturing
Open in API
Filings indexed 457 across all filing types
Latest filing 2021-04-01 Capital/Financing Update
Country US United States of America
Listing US BEAM

About Beam Therapeutics Inc.

https://beamtx.com/

Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines using its proprietary base editing technology. This approach is designed to make precise, single-letter edits to the genome without causing double-stranded breaks in the DNA, aiming to overcome the limitations of traditional gene editing methods. The company's pipeline focuses on creating potential life-long cures for genetic disorders, including sickle cell disease, beta-thalassemia, and alpha-1 antitrypsin deficiency. Beam Therapeutics is also advancing a suite of delivery technologies, such as electroporation, nonviral, and viral modalities, to deliver its base editors to target cells.

Recent filings

Filing Released Lang Actions
S-3ASR
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is a registration statement for securities offerings under the Securities Act of 1933. It includes a prospectus describing the types of securities to be offered (common stock, preferred stock, debt securities, warrants, units) and general terms. The document is not a financial report, earnings release, or management discussion. It is a regulatory filing related to capital raising and securities registration. The Form S-3 is a standard SEC filing for registering securities offerings and is not an annual report, audit report, or other report types listed. Therefore, the most appropriate classification is Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2021-04-01 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2021-03-23 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2021-03-23 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2021-03-23 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by Beam Therapeutics Inc. It registers additional shares under the company's 2019 Equity Incentive Plan and Employee Stock Purchase Plan. The document includes details about the securities to be registered, calculation of registration fees, incorporation by reference of prior filings including the Annual Report on Form 10-K, and exhibits such as the certificate of incorporation and bylaws. Form S-8 is a registration statement used for securities issued under employee benefit plans and is not a financial report, earnings release, or management discussion. It is a regulatory filing related to securities registration and compliance with the Securities Act of 1933. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is substantial (11,970 characters), and it is not merely an announcement or certification but a full registration statement filing.
2021-03-17 English
10-K
Annual Report FY 2020
2021-03-15 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.